<DOC>
	<DOCNO>NCT00530595</DOCNO>
	<brief_summary>Cardiovascular disease lead cause mortality patient hemodialysis therapy ( HD ) , account 30 50 % death . Although angiotensin receptor blocker ( ARBs ) effective patient diabetes chronic kidney disease reduce prevent cardiovascular disease , decisive study demonstrate treatment ARBs effective patient HD .</brief_summary>
	<brief_title>Effects Angiotensin Receptor Antagonist Prohibiting Cardiovascular Events Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>30 80 year age Receiving hemodialysis least 12 month le 5 year Predialysis systolic blood pressure 160 mmHg , 150 mmHg patient receive antihypertensive agent . Use angiotensin receptor blocker angiotensin convert enzyme inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>hemodialysis</keyword>
</DOC>